Home    
Thursday, October 22, 2009 8:39:30 PM ET
What's New | Quick Reference | Contact Us | Site Map

  Home
  Vaccines · Diseases
  Resource Center
  Education Toolkit
  Safety/Adverse Event
  Imz University


 

Last Updated: 22 Oct 09
    Meningococcal
    Neisseria meningitidis
 


meningococcal bacteria
Meningitis is an infection of the fluid of a person's spinal cord and the fluid that surrounds the brain. People sometimes refer to it as spinal meningitis. Meningitis is usually caused by a viral or bacterial infection. Knowing whether meningitis is caused by a virus or bacterium is important because the severity of illness and the treatment differ. Viral meningitis is generally less severe and resolves without specific treatment, while bacterial meningitis can be quite severe and may result in brain damage, hearing loss, or learning disability. For bacterial meningitis, it is also important to know which type of bacteria is causing the meningitis because antibiotics can prevent some types from spreading and infecting other people. Before the 1990s, Haemophilus influenzae type b (Hib) was the leading cause of bacterial meningitis, but new vaccines being given to all children as part of their routine immunizations have reduced the occurrence of invasive disease due to H. influenzae. Today, Streptococcus pneumoniae and Neisseria meningitidis are the leading causes of bacterial meningitis.

 
    VIS   SHORTAGES       PACKAGE INSERTS          INFO PAPER

WHAT'S NEW?more...
  Menomune (Sanofi-Pasteur)
 Package Insert
  Menactra (Sanofi-Pasteur)
 Package Insert
  Meningococcal Vaccines: What You Need to Know
 Vaccine Information Statement (Interim)

NEWSmore...
dot MSNBC 31 Aug 09
Shots can protect youth from deadly meningitis

CLINICALmore...
  Improved Supply of Meningococcal Conjugate Vaccine, Recommendation to Resume Vaccination of Children Aged 11--12 Years
 MMWR
  Inadvertent Misadministration of Meningococcal Conjugate Vaccine --- United States, June--August 2005
 MMWR
  Vaccine Update (Menactra)  PDF  16 Nov 05
 Sanofi Pasteur

ACIP GUIDELINESmore...
  Recommendation for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2-10 Years at Increased Risk for Invasive Meningococcal Disease
 Recommendation of the Advisory Committee on Immunization Practices (ACIP)
  Revised Recommendations of the Advisory Committee on Immunization Practices to Vaccinate All Persons Aged 11--18 Years with Meningococcal Conjugate Vaccine
  Prevention and Control of Meningococcal Disease PDF  27 May 05
 Recommendations of the Advisory Committee on Immunization Practices (ACIP)

DHB RECOMMENDATIONSmore...
  Recommendation on the Use of Meningococcal Vaccine
 Recommendations of the Armed Forces Epidemiological Board (AFEB)
  Recommendation on the Use of Meningococcal Vaccine
 Recommendations of the Armed Forces Epidemiological Board (AFEB)

SERVICE MESSAGESmore...
  ALARACT PDF  21 Jan 06
 ADOPTION OF NEW MENINGOCOCCAL CONJUGATE VACCINE, MENACTRA

SHORTAGEmore...
  Improved Supply of Meningococcal Conjugate Vaccine, Recommendation to Resume Vaccination of Children Aged 11--12 Years
 MMWR

MMQC MESSAGESmore...
  MMQC-08-1033
 MERCK / PEDVAXHIB (MENINGOCOCCAL PROTEIN CONJUGATE) AND COMVAX (MENINGOCOCCAL PROTEIN CONJUGATE) AND HEPATITIS B (RECOMBINANT) VACCINE / ADDITIONAL INTERIM RECOMMENDATIONS
  MMQC-06-1362
 SANOFI PASTEUR MENACTRA® (MENINGOCOCCAL VACCINE) AVAILABILITY / UPDATED INFORMATION
  MMQC-06-1321
 MISADMINSTRATION OF MENINGOCOCCAL CONJUGATE VACCINE / DEPARTMENT OF DEFENSE PATIENT SAFETY CENTER ADVISORY

SAFETY/ADVERSE EVENTSmore...
  FDA and CDC Issue Alert on Menactra Meningococcal Vaccine and Guillain Barre Syndrome PDF  30 Sep 05
 The Food and Drug Administration

CONSUMERmore...
  Meningococcal Meningitis
  Meningococcal Disease Information

QUESTIONS & ANSWERSmore...
 The Disease
 Meningococcal Vaccine


PACKAGE INSERTmore...
  Menomune (Sanofi-Pasteur)
 Package Insert
  Menactra (Sanofi-Pasteur)
 Package Insert
About Us AVIP                  SVP Security Notice and Link Disclaimer